BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uchiyama AAT, Silva PAIA, Lopes MSM, Yen CT, Ricardo ED, Mutão T, Pimenta JR, Machado LM, Shimba DS, Peixoto RD. Proton Pump Inhibitors and Oncologic Treatment Efficacy: A Practical Review of the Literature for Oncologists. Curr Oncol 2021;28:783-99. [PMID: 33546228 DOI: 10.3390/curroncol28010076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Mudie DM, Stewart AM, Rosales JA, Biswas N, Adam MS, Smith A, Craig CD, Morgen MM, Vodak DT. Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs. Pharmaceutics 2021;13:557. [PMID: 33921109 DOI: 10.3390/pharmaceutics13040557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li J, Nickens D, Wilner K, Tan W. Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer and EGFR-Activating Mutations. Oncol Ther 2021. [PMID: 34120312 DOI: 10.1007/s40487-021-00156-2] [Reference Citation Analysis]
3 Kalinin S, Malkova A, Sharonova T, Sharoyko V, Bunev A, Supuran CT, Krasavin M. Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors. Int J Mol Sci 2021;22:13405. [PMID: 34948200 DOI: 10.3390/ijms222413405] [Reference Citation Analysis]
4 Bridoux M, Simon N, Turpin A. Proton Pump Inhibitors and Cancer: Current State of Play. Front Pharmacol 2022;13:798272. [DOI: 10.3389/fphar.2022.798272] [Reference Citation Analysis]
5 Xia J, Zhu J, Li L, Xu S, Niu B. Concomitant Gastric Acid Suppressants on the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Meta-Analysis. International Journal of Clinical Practice 2022;2022:1-14. [DOI: 10.1155/2022/3102641] [Reference Citation Analysis]
6 Mudie DM, Stewart AM, Rosales JA, Adam MS, Morgen MM, Vodak DT. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021;13:1257. [PMID: 34452217 DOI: 10.3390/pharmaceutics13081257] [Reference Citation Analysis]